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A B S T R A C T The influence of the administration of
pharmacologic doses of hydrocortisone on the extent and
severity of acute myocardial ischemic injury and on sub-
sequent necrosis after acute coronary occlusion was inves-
tigated in 28 dogs. In order to study acute myocardial in-
jury, repeated epicardial electrocardiograms were re-
corded from 10 to 15 sites on the anterior surface of the
left ventricle. Average ST segment elevation (ST) and
the number of sites in which ST segment elevation ex-
ceeded2mV (NST), indices of the magnitude and extent
of myocardial injury, respectively, wereanalyzed at30and
60 min after coronarv occlusion. In the control g,-oup ST
and NST did not change significantly in this time in-
terval while in the treated group, which received 50
mg/kg hydrocortisone just after the 30 min recording,
ST fell from 3.5±0.8 to 1.1+0.4 mV (P<0.01) and
NST was reduced from 6.7±1.1 to 1.4±0.8 (P < 0.01).
In order to study the influence of hydrocortisone on
r. crosis, epicardial ST segment elevation 15 min after
coronary occlusion was compared to myocardial creatine
phosphokinase activity (CPK) and histologic appearance
24 h later in each site. In a control group (14 dogs) a
relationship was established between ST segment ele-
vation at 15 min (in millivolts) and CPK activity (in
international units per milligram of protein) 24 h later:
log CPK = - 0.0611ST + 1.26 (N:= 102 specimens,
r =- 0.79). In the treated groups, hydrocortisone
(50 mg/kg i.v.) was given either at 30 min after oc-
clusion (seven dogs) or at 6 h after occlusion (six dogs).
Both groups received supplementary doses of hydrocor-
tisone (25 mg/kg) 12 h after occlusion. The two treated
groups exhibited less CPK depression than that expected
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from ST segment elevation at each site, with slopes of
the regression lines which were significantly less steep:
log CPK =- 0.0288ST + 1.26 (N = 48, r = -0.71)
and log CPK = - 0.0321ST + 1.31 (N = 48, r= -
0.76) in the i h and 6 h groups, respectively. Histologi-
cally, sites with ST segment elevations of less than 2 mV
at 15 min after occlusion exhibited normal appearance 24
h later. Sites with ST segment elevations (> 2 mV) in
the control group showed histologic changes compatible
with early myocardial infarction in 96% of specimens,
while this occurred only in 61% and 63% of specimens,
respectively, in the treated groups, showing that over
one third of the sites were protected from undergoing
necrosis due to the intervening hydrocortisone treatment.
Thus pharmacological doses of hydrocortisone prevent
myocardial cells from progressing to ischemic necrosis
even when administration is initiated 6 h after coronary
occlusion.
INTRODUCTION
Recent investigations in our laboratory have begun to
delineate factors determining the extent and severity of
myocardial ischemic injury and subsequent necrosis
after acute coronary occlusion. The possibility of modi-
fication of infarct size has been demonstrated both in
experimental animals and in patients, and it has been
observed that interventions which either decrease mvo-
cardial requirements or increase oxygen supply reduce
the extent and severity of myocardial ischemic injury and
subsequent necrosis, while those which augment oxygen
demands or decrease oxygen supply increase myocardial
damage (1-3). In addition, it has been demonstrated
that interventions which may exert metabolic effects,
such as glucose-insulin-potassium, act to protect ischemic
myocardium from necrosis (4). The possibility that
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on infarct size has been investigated by a number of
workers, but the results have been conflicting (5-7).
Since the newly developed methods for assessing myo-
cardial ischemic injury are more sensitive and reliable
than those previously available, we have undertaken to
evaluate the effects of pharmacologic doses of corti-
costeroids on experimental infarcts.
METHODS
The study was divided into two parts: (a) the examination
of the effects of hydrocortisone administered during the 1st
h after occlusion on the electrocardiographic signs of is-
chemic injury, and (b) their effects on enzymatic and
histologic signs of necrosis and infarction 24 h later in
animals receiving the steroid i and 6 h after coronary
occlusion. The basic techniques utilized in this investigation
have been described in detail (14).
The studies were carried out in 28 mongrel dogs of both
sexes weighing from 18 to 27 kg, anesthetized with sodium
thiamylal (25 mg/kg) with respiration maintained mechan-
ically through a cuffed endotracheal tube. Aortic pressure
was monitored through a catheter inserted through the
left common carotid artery using a Statham P23Db strain
gauge (Statham Instruments, Inc., Oxnard, Calif.). The
left jugular vein was catheterized and used as a route of
administration of fluids and drugs. The thorax was entered
through the fifth left intercostal space and the heart sus-
pended in a pericardial cradle, so that the anterior aspect
of the left ventricle was well exposed. The left anterior
descending coronary artery or its apical branch was dis-
sected free so that it could be occluded when desired. 10-14
sites on the anterior surface of the left ventricle were
selected arbitrarily at the outset of each experiment for
recording of unipolar epicardial electrocardiograms so that
some were clearly within the area supplied by the artery
to be occluded and others were located in regions whose
perfusion would not be affected by the coronary ligation
and thus could serve as internal controls. The epicardial
electrocardiograms were recorded in anatomically recogniz-
able sites, such as branching of arteries or intersection
of arteries and veins. The technical details were described
previously (1).
The extent and severity of acute myocardial ischemic
injury was determined by analysis of the ST segments in
epicardial electrocardiographic maps obtained from these
sites before and at intervals after occlusion. The number
of sites with abnormal ST segments (elevations of more
than 2 mV) was taken as an index of the extent of
ischemic injury (NST) 1 and the average of the sum of
ST segment elevation at all sites (ST) was used as an
index of the severity of ischemic injury. Sites which had
ST segment depression were considered as having zero ST
segment elevation since in this model, creatine phosphokinase
activity (CPK) and histology of these sites has been
found to be normal 24 h after occlusion. The animals were
divided into two groups, a control group (14 dogs) and
a treated group (14 dogs). In seven dogs from the control
group and in seven treated dogs the effect of corticosteroid
'Abbreviations used in this paper: CPK, creatine phos-
phokinase activity; NST, number of sites in which ST
segment elevation exceeded 2 mV; ST, average ST segment
elevation.
administration on acute ischemic injury was determined by
recording epicardial electrocardiographic maps just before,
and 15, 30, and 60 min after coronary artery ligation. The
dogs in the treated group received hydrocortisone hemi-
succinate (50 mg/kg) intravenously as a bolus just after
the 30 min postocclusion map. The effect of this treatment
was evaluated by comparing the changes in average NST
and ST in the control and treatment groups at 30 and 60
min after occlusion.
The effect of corticosteroid administration on the devel-
opment of myocardial infarcts after coronary occlusion was
studied by measurement of myocardial CPK and by histo-
logic examination of tissue obtained post mortem 24 h after
occlusion in all 14 control dogs and 13 of the treated group.
After the final electrocardiographic map, the chest was
closed anatomically and drained by a chest tube to constant
underwater suction. The animals were then allowed to
recover but were maintained under sedation with small
additional doses of sodium thiamylal. All animals received
40 cc/kg per 24 h of normal saline by intravenous drip.
Aortic pressure and lead aVF of the electrocardiogram
were constantly monitored using a Brush oscillographic
recorder (Brush Instruments, Div. Clevite Corp., Cleveland,
Ohio). The 13 treated animals were divided into two sub-
groups: seven dogs received 50 mg/kg hydrocortisone 30
min after occlusion and the other six dogs received the
same dose 6 h after coronary occlusion. An additional dose
of hydrocortisone (25 mg/kg) was administered intrave-
nously to both groups 12 h after occlusion.
24 h after occlusion all animals were reanesthetized with
sodium thiamylal, reintubated, and again placed on the respi-
rator. The chest was reopened, the heart excised and
transmural specimens for CPK analysis were rapidly ob-
tained from the same sites at which epicardial electrocardio-
grams had been recorded 24 h previously. The biopsies were
taken with a stainless steel canulla and the specimens ob-
tained were roughly of the same diameter as the cotton
wick electrode (7 mm) and weighed approximately 0.5 g.
They were placed in iced homogenizing medium and pre-
pared for assay of CPK activity as previously described
(1). This biochemical determination was carried out by a
technician unaware of the origin of the specimen. Trans-
mural tissue samples, for histological and histochemical
analysis, from sites immediately adjacent to the site of
biopsy for CPK were taken with a scalpel, fixed in abso-
lute ethanol, and stained with hematoxylin-eosin and Best's
carmine stain.
The effects of interventions on the development of signs
of myocardial infarction were analyzed exactly as described
previously (1, 3, 4). The relationships between ST segment
elevation 15 min after occlusion (i.e., before any treatment),
and myocardial CPK activity and histologic appearance of
the specimens obtained 24 h later from the same sites in
the control group was compared to those observed in the
treated group. Myocardial CPK specific activity was de-
termined in the 31,000 g supernatant fraction of the tissue
homogenate at 30'C by the back reaction technique of
Rosalki (8). Protein was determined by the Biuret reaction
and activity was expressed in international units (micro-
moles substrate converted per minute) per milligram pro-
tein. The results of duplicate determination of CPK agreed
within 3% (1).
Histopathologic examination was carried out by a path-
ologist who was unaware of the origin of the coded sections.
The hematoxylin-eosin-stained sections were graded for the
presence or absence of early signs of ischemic necrosis such
as more intense eosinophilic staining, nuclear changes, loss
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were analyzed by comparing epicardial ST segment eleva-
tion at each site 15 min after occlusion (i.e, before any drug
administration) with the histologic appearance of the tissue
obtained from the same epicardial site 24 h later.
The possibility that hydrocortisone could affect CPK
activity or the synthesis of CPK was investigated by in-
cubating dog heart CPK purified according to Noda, Kuby,
and Lardy (9) and slices of dog heart with 1 mg/ml of
hydrocortisone at 370C for 8 h in duplicate experiments.
Any influence of hydrocortisone on the CPK assay was
examined by including it at an appropriate concentration in
the assay mixture of a CPK standard (Worthington Bio-
chemical Corp., Freehold, N. J). There was no alteration
in CPK activity due to hydrocortisone addition in any of
the above experiments.
RESULTS
Effect of hydrocortisone on acute myocardial ischemic
injury. In the six animals in the control group in
which ST segment maps were obtained 30 and 60 min
after occlusion there was no significant spontaneous
decrease in the indices of the extent and severity of acute
myocardial ischemic injury. In this group, ST was
3.0±1.2 mV (SEM) at 30 min and 2.9±1.4 mV at 1 h
after occlusion (NS), while NST changed from 5.0+1.5
to 4.2±1.5 sites (NS). In contrast, in the group which
received hydrocortisone (50 mg/kg i.v.) just after the
30 min map, a substantial decrease in both the extent and
severity of myocardial ischemic injury was observed;
ST decreased from 3.5±0.8 at30min to 1.1±0.4 mV at 60
min (P < 0.01), while NST fell from 6.7±1.1 to 1.4±0.8
(P < 0.01) (Fig. 1). Thus, the administration of hydro-
cortisone 30 min after coronary artery occlusion de-
creases electrocardiographic signs of acute ischemic
injury to the myocardium. The effects could not be com-
pared 24 h postocclusion due to the presence of peri-
carditis and of multifocal ventricular tachyarrhythmias
which occurred in some dogs at this time.
Effect of hydrocortisone on myocardial CPK activity.
The relationship between epicardial ST segment elevation
15 min after coronary occlusion and myocardial CPK
activity in the same sites 24 h later was determined in
dogs from the control group. Sites outside the ischemic
area always had normal ST segments (ST elevation < 2
mV) and showed normal CPK activity 24 h later (18.8
±4.1 IU/mg prot. [average-'-SD]); while sites within
the ischemic area (i.e., sites exhibiting ST segment ele-
vation >2 mV) always had decreased CPK activity
(Fig. 2). In 102 specimens from the 14 control dogs,
CPK activity 24 h after occlusion was found to be expo-
nentially and inversely related to the degree of ST seg-
ment elevation recorded 15 min after occlusion from the
same site. The regression equation of the line repre-
senting this relationship is log CPK (in IU/mg prot.)
= -0.0611ST (in millivolts) + 1.26 (r=- 0.79, Fig.
3).
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FIGURE 1 The effects of hydrocortisone on average ST
segment elevation (ST, left panel) and on the number of
sites with abnormally elevated ST segments (NST, right
panel). Every line represents one animal. Open symbols
are the ST and NST value 30 min after occlusion (just
before hydrocortisone administration), solid symbols are the
values 30 min later, i.e., 60 min after occlusion. Mean and
standard errors are denoted by the squares connected by
dotted lines.
In the group treated with hydrocortisone, sites with
normal ST segments at 15 min also showed normal
CPK activity 24 h later. Sites which exhibited ST seg-
ment elevations 15 min after occlusion showed less CPK
depression than expected and several exhibited CPK val-
ues within the normal range. Fig. 4 is an example from
a dog which received hydrocortisone 6 h postocclusion
in which CPK activity was much less depressed than
that expected from the height of the ST segment at 15
min. The slope of the regression line was significantly
lower in the two treated groups than in the control group.
In the animals which received hydrocortisone 30 min
after occlusion, the regression equation was log CPK
= -0.0288ST + 1.26 (r = -0.71, Fig. 3). This indi-
cates that for any given level of ST segment elevation
there was less CPK depletion than predicted from the
control group. In the 6 dogs (48 biopsies) in which
treatment started 6 h after occlusion there was also
less CPK depression than that expected from epicardial
ST segment elevation 15 min after occlusion: log CPK
= - 0.0321ST + 1.31 (r = -0.76, Fig. 3). Thus, hy-
drocortisone treatment exerts a protective effect on the
myocardium even when started 6 h after occlusion, as
estimated by the decreased degree of CPK depression.
Effect of hydrocortisone on histologic appearance. In
the control group, 27 out of 28, i.e., 96% of the sites with
normal ST segments (0-2 mV elevation) 15 min after
occlusion showed normal histologic appearance 24 h
later (Fig. 5, panel 1; Table I). Also 51 of 53, i.e., 96%
of the sites from control animals which had abnormal
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FIGURE 2 Relationship between ST segment elevation 15 min after occlusion and CPK and
histology 24 h later in an experiment in the control group. Left panel: a diagramatic repre-
sentation of the anterior surface of the heart with its arteries (LA, left atrial appendage;
LAD, left anterior descending coronary artery). The shaded area represents the area of ST
segment elevation after occlusion. The circles represent sites from which biopsies were taken.
Right panel: comparison between ST segment elevation 15 min after occlusion and CPK and
histologic analysis 24 h later in the same sites.
ST segments (> 2 mV elevation) 15 min after occlu-
sion showed pathologic changes consistent with early
myocardial ischemic necrosis 24 h later (Fig. 5, panel 2;
Table I). In contrast, in the dogs which received hy-
drocortisone 30 min after occlusion 15 of 41, i.e., 37%
of sites with abnormal ST segment elevations exhibited
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FIGURE 3 Relationship between ST segment elevation 15
mmn after occlusion and log CPK values from specimens
obtained in the same sites 24 h later. Line A: occlusion
alone: log GPK =- 0.06115T + 126 (r = -0.79, 14 dogs,
102 biopsies). Line B. hydrocortisone 30 mmn after occlu-
sion: log CPK =- 0.02885T +1.26, r =- 0.71, 7 dogs, 56
biopsies). Line C: hydrocortisone 6 h after occlusion: log
CPK = -0.0321 ST + 1.31 (r = -0.76, 6 dogs, 48 biopsies).
normal histologic appearance 24 h later (Fig. 5, panel
3; Table I). All 15 out of 15 sites with normal ST
segments showed normal histology (Table I). The re-
sults of Best's carmine staining for glycogen granules
were similar to those of hematoxylin-eosin staining.
Whenever a section from a site was classified as patho-
logical, Best's carmine-stained sections from the same
site showed depletion of glycogen granules. Sites from
the hydrocortisone-treated group which had abnormal
electrocardiograms but which had preservation of nor-
mal histologic appearance also showed preserved gly-
cogen stores. Thus, in the control group, 96% of sites
with normal ST segments (0-2 mV) 15 min after oc-
clusion showed preservation of glycogen granules 24 h
later. On the other hand, 96% of sites with abnormal
ST segments (> 2 mV) at 15 min after occlusion
showed depletion of glycogen graules 24 h later. In the
hydrocortisone-treated group 100% of sites with normal
ST segment elevation showed preserved glycogen gran-
ules and in sites with ST segment elevation 37% of sites
showed preserved glycogen granules.
In the dogs which were treated with hydrocortisone
6 h after occlusion, all 15 out of 15 sites with normal ST
segments (elevation 0-2 mV) at 15 min, showed normal
histology 24 h later (Table I). Sites with abnormal ST
segment elevations 15 min after occlusion exhibited
normal histology in 14 of 41 instances or 39%. (Fig. 4,
Table I).
Other effects of hydrocortisone administration. Hy-
drocortisone exhibited no observable effects on the de-
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ST SEGMENT CPK
ISITE ELEVATION(mV) (I U/mg prot) HISTOLOGY
A 0 2 0 7 NORMAL
B 0 2 0 8 NORMAL
C 7 6 5 ABNORMAL
D 8 6 3 ABNORMAL
E 6 8 5 ABNORMAL
F 7 6,8 ABNORMAL
G 5 8 8 ABNORMAL
H 5 8.4 ABNORMALo sIrE OF BIOPSY
AREA OF STr sEImEr
N"ELEVATrION
FIGURE 4 Example of an experiment from the group receiving hydrocortisone 6 h after
occlusion. Left panel: diagramatic representation of the heart. The shaded area represents the
area of ST segment elevation 15 min aftr infarction, circles represent the sites where biopsies
were taken. Right panel: comparison between ST segment elevation 15 min after coronary
occlusion and CPK activity and histologic changes 24 h later. Note sites C-F and H, which
had elevated ST segments 15 min after occlusion but which showed normal CPK activity
and preserved histology 24 h later.
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FIGURE 5 Left panel: histology from sites without ST segment elevation. Epicardial electro-
cardiogram (ECG) 15 min after occlusion and hematoxylin-eosin-stained sections obtained
from the same sites 24 h later. Note the normal myocardial structure. Middle panel: histology
from a site with ST segment elevation from the control group. Epicardial ECG 15 min after
occlusion and hematoxylin-eosin stain from the same sites 24 h later. Note the abnormalities
described in the text. Right panel: histology from a site with ST segment elevation of the
same magnitude as that in the middle column, in a dog from the group treated with hydro-
cortisone. Epicardial ECG 15 min after occlusion. Note the preservation of normal myocardial
histologic appearance.
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SITE ST SEGMENT CPK HISTOLOGY ELEVATION T1) (IU/mgprot.)
A 0 22.7 NORMAL
B 0 23.7 NORMAL
C 5 22.4 NORMAL
D 6 19.4 NORMAL
E 2 24.8 NORMAL
F 5 21.3 NORMAL
G 6 16.6 ABNORMAL
H 4 21.6 NORMALTABLE I
Comparison of Electrocardiographic and Histologic Changes
ST segment elevation*
Histologyt
Normal (0-2 mV) Abnormal (>2 mV)
No. specimens/ Normal Abnormal No. specimens/ Normal Abnormal
No. animals specimens specimens No. animals specimens specimens
% No % %
1 Control group 28/8 96 4 53/8 3 96
2 Hydrocortisone group 30/14 100 0 82/14 3811 62
2a Hydrocortisone at 30 min§ 15/7 100 0 41/7 3711 63
2b Hydrocortisone at 6 hr¶ 15/7 100 0 41/7 3911 61
* ST segment elevation 15 min after a simple coronary occlusion, i.e., before hydrocortisone administration.
: Histologic findings 24 hr after coronary occlusion.
§ Hydrocortisone treatment started 30 min after coronary occlusion.
Hydrocortisone treatment started 6 hr after coronary occlusion.
¶Significantly greater than group 1 (P < 0.005).
velopment of the ventricular tachyarrhythmias commonly
seen in dogs after coronary ligation. There was also no
statistical difference between the control and hydro-
cortisone-treated groups in mean arterial pressure at 6,
12, and 24 h after coronary occlusion. After the bolus
intravenous injections of hydrocortisone a transient ar-
terial hypotension was observed in all dogs. When 50
mg/kg was injected at 30 min and 6 h after occlusion
there was a fall of 45±5 mm Hg from the initial mean
arterial pressure of 111±10 mm Hg. The arterial pres-
sure returned to preinjection levels after an average of
170±30 s. When a dose of 25 mg/kg was injected 12 h
after occlusion, mean arterial pressure fell 36±5 mm Hg
from an average of 116±8 mm Hg, and returned to
previous levels after 110±4 s.
DISCUSSION
With the advent of effective intensive coronary care,
primary arrhythmias are usually effectively controlled
in patients hospitalized with acute myocardial infarction,
and cardiac pump failure manifested by cardiogenic
shock and/or pulmonary edema has emerged as the
leading cause of death (10). Since it is becoming ap-
parent that development of cardiogenic shock depends on
the quantity of left ventricular myocardium which is
spared infarction (11-13), limitation of the amount of
necrosis resulting from a given occlusive event should
be a major objective of treatment (1-4). Accordingly, an
effort to decrease infarct size after coronary occlusion is
potentially of considerable clinical importance and led us
to evaluate the possible effects of corticosteroid therapy.
The model used in this study was employed only to
answer the question of whether hydrocortisone influ-
ences infarct size after coronary occlusion and is not
suitable for study of the hemodynamic effects of such
changes in view of the small hemodynamic alterations
that occlusions at the midportion of the left anterior
coronary artery produce in dogs.
The value of these agents in myocardial infarction has
been controversial, Johnson, Scheinberg, Gerisch, and
Saltzstein (5) showed a reduction in the area of infarcts
experimentally produced in dogs treated with cortisone
(1-2 mg/kg) intramuscularly each day for 2-3 wk after
coronary ligation and noted evidence of increased inter-
coronary anastomoses. However, Opdyke, Lambert,
Stoerk, Zanetti, Kuna (6) and Hepper, Pruitt, Donald,
and Edwards (7) were unable to confirm these results.
Similarly, several clinical investigations showed reduced
mortality in patients with acute myocardial infarction
treated with hydrocortisone (14-17), while other stud-
ies have not confirmed this observation (18).
The methods which we have developed for studying
development of experimental myocardial infarcts are
more sensitive and reliable than the measurement of gross
infarct size used in previous investigations, which neces-
sitated comparisons of groups of animals. The inherent
difficulty of the latter approach has been well recognized
by earlier investigators who noted that the size of an in-
farct does not correlate well with the site of occlusion
(6, 19), and that there is considerable variation in the
size of infarcts within a control series with a standard
point of occlusion. This observation has been borne out
by our own experience. Since production of standard
experimental infarcts by coronary occlusion is not readily
accomplished in the dog, it becomes difficult to demon-
strate a statistically significant effect of treatment in
this species. The method used in this study obviates
this problem because the amount of eventual necrosis is
predicted for each site of the myocardium to be sampled.
WVhen no treatment intervenes, ST segment elevation 15
min after occlusion reliably predicts myocardial CPK
depletion and histologic, histochemical. and ultrastruc-
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as shown in previous studies (1, 3, 4) as well as in the
control group of dogs employed in this investigation. It
is notable that epicardial ST segment elevation 15 min
after occlusion also predicts gross anatomic infarct size
1 wk after occlusion (20).
In the dogs which received hydrocortisone, the damage
observed biochemically (i.e., myocardial CPK depres-
sion) and histologically 24 h after occlusion, was much
less than that expected from the initial ST segment map
and it is therefore concluded that hydrocortisone protects
portions of the ischemic myocardium from undergoing
necrosis. The possibility that hydrocortisone might in-
duce an increased synthesis of CPK was explored in
experiments in which tissue slices of the myocardium
w-ere incubated with and without hvdrocortisone; their
CP'K activities were comparable, providing no evidence
for such synthesis. Also, sites with no ST segment ele-
vation showed no differences in CPK activity in the con-
trol and the lhydrocortisone-treated groups. The possi-
bility that hvdrocortisone would prevent the loss of
CPK from the cells or its entrance to the blood was also
considered. Wh1ile not excluded, it is unlikely in view
of the normal histologic appearance and the conserva-
tion of glvcogen granules in hvdrocortisone-treated
animals.
Hydrocortisone is also known to decrease the inflam-
matory cell infiltration, one of the histologic criteria for
determining the presence of infarction, but whenever the
histologic appearance was considered normal it was
judged also on the presence of muscular cross-striation.
the absence of karyolysis or karyorhexis and the presence
of glycogen granules.
Hydrocortisone acts not only when given 30 min after
occlusion but also when administered for the first time
61 after occlusion. This observation has important prac-
tical implications. It suggests that therapy might still be
effective when started as late as a number of hours af-
ter the onset of occlusion, at a time when the patient may
already be admitted to a hospital and his condition recog-
nized. This observation is of theoretical importance as
well, because it suggests that some myocardial injury is
reversible even after 6 h of coronary occlusion. Irreversi-
ble damage after coronary occlusion is known to occur
in some cells within the first 45 min (21-23) and it has
been shown to take place as early as 21 min after oc-
clusion (24). The proportion of reversible and irreversi-
ble damage to myocardial cells after several hours of
ischemia is difficult to determine, but some investigators
believe that after 1-2 h, most of the cells are irreversibly
injured (25). However, using the methods currently
available it was possible to show that enzymatic and
histologic evidence of myocardial damage can be de-
creased substantially 3 h1 after occlusion bv the simultane-
ous administration of propranolol and glucose-insulin-
potassium (4) and by coronary artery reperfusion (3,
20). The present investigation extends this observation
to show that an intervention (i.e., hydrocortisone ad-
ministration) can partially protect the myocardium
from ischemic necrosis, even when given as late as 6 h
after occlusion. This finding is consistent with the obser-
vation that electrocardiographic signs of ischemic in-
jury decrease when proI)oranolol is administered up to 6
h after occlusion (2).
The electrocardiographic observations ma(le during the
1st h of these experiments demonstrate that hydro-
cortisone treatment decreases the extent and severity of
acute ischemic injury after coronary occlusion and they
are therefore in agreement with earlier results (26).
This decrease in the electrocardiographic signs of in-
jury makes it feasible to monitor the effects of this drug
atraumatically in patients by ST segment mapping using
multiple unipolar precordial leads (2).
While this study did not attempt to elucidate the
mechanism of action of hydrocortisone's protective ef-
fect, there are several possible explanations which wvar-
rant consideration. Lysosomes occur in myocardial cells
(27-31) and it is possible that steroids protect the myo-
cardium by their well-known stabilizing effect on lysoso-
mal membranes (32-34). These organelles, which are
disrupted by acidotic conditions in hypoxic cells, re-
lease acid hvdrolases which ma! contribute to early ir-
reversibility of cell damage. There is evidence that a
significant proportion of myocardial lysosomal hydrolytic
activity shifts from particulate to unbound tissue frac-
tions within the first few hours of ischemia (35. 36). If
these data are applicable to our experimental model, then
the protective effect of hydrocortisone administered 30
min after occlusion could be explained by decreased
autolysis. In the group which received the drug 6 h after
occlusion, stabilization of the phagocytic vacuoles of in-
filtrating inflammatory cells might reduce their hetero-
lvtic activity through a similar mechanism.
There are isolated reports of other effects of corticos-
teroids which might also contribute to the protection of
mvocardium from ischemic damage in acute mvocardial
infarction. For example, corticosteroids have been re-
ported to decrease oxygen consumption of isolated rat
myocardium (37) and to shift the oxyhemoglobin dis-
sociation curve to the right (38). On the other hand,
the decrease in mvocardial necrosis observed in this
study could not be attributed to hvdrocortisonie's anti-
arrhythmic properties ('39-41), since no reduction in the
late tach-varrhvthminas which delvelop in the dog after
coronary occlusion w\\ere observed in this investigation.
Previous experiments showed that all positive inotropic
interventions which have been examined in the non-
failing heart increased the extent of ischemic injury
Corticosteroids and Infarct Size 605and subsequent necrosis after coronary occlusion (1, 2).
Therefore, it is extremely unlikely that the positive ino-
tropic effect ascribed to large doses of corticosteroids
(42, 43) could provide an explanation for their beneficial
action on infarct size observed in these experiments. On
the other hand, the beneficial effect of corticosteroids in
the treatment of cardiogenic shock (44-46) may be at
least partially attributable to a reduction in ischemic
injury. The observation that positive inotropic inter-
ventions decrease myocardial damage in the failing
canine heart (47) suggests that hydrocortisone's positive
inotropic effect in cardiogenic shock may contribute to
a reduction in myocardial damage.
Corticosteroids have other effects which should be
considered when their administration in the context of
acute myocardial infarction is considered. The transient
hypotension observed in the present experiments may be
explained by the known vasodilatory action of steroids
(43, 45, 48, 49). However, it is noteworthy that in
studies of corticosteroid administration to patients with
acute myocardial infarction, no deleterious hemodynamic
effects have been reported (15-18). Corticosteroids are
also known to alter the healing and granulation of surgi-
cally induced wounds (50-52). However, in acute myo-
cardial infarction hydrocortisone (2-10 mg/kg per day)
did not affect healing from 2 to 60 days after acute
experimental coronary occlusion (7, 53, 54) and al-
though the doses used were less than those employed in
the present study, the course of treatment was longer.
The present studies showing the reduction in experi-
mental myocardial necrosis should be extrapolated to
patients only with extreme caution for several reasons:
(a) the obvious differences between this experimental
model and the patient with acute coronary occlusion,
(b) the lack of knowledge of the mechanisms of action
of hydrocortisone in reducing infarct size in this experi-
mental model, and (c) the lack of information concern-
ing the influence, if any, of hydrocortisone on the healing
phase of acute myocardial infarctions. Nevertheless, the
reduction in infarct size noted in these experiments does
provide leads worthy of further investigation with a
view to future clinical trial.
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